How many insider declarations has 5AM Ventures V, L.P. filed?

5AM Ventures V, L.P. has filed 2 public insider declarations with SEC (Form 4).

What is 5AM Ventures V, L.P.'s role?

5AM Ventures V, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does 5AM Ventures V, L.P. report trades for?

5AM Ventures V, L.P. reports trades for Entrada Therapeutics, Inc..

← Executives ★ Sign in to follow

5V

5AM Ventures V, L.P.

·SEC (Form 4)

Entrada Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the full record of transactions filed by 5AM Ventures V, L.P.. Insider active across 1 company, notably Entrada Therapeutics, Inc.. In total, 2 disclosures have been logged. History available since 30 July 2026. The latest transaction was disclosed on 30 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to 5AM Ventures V, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Entrada Therapeutics, Inc. (US)

申报2 总计

●

5AM Ventures V, L.P.

Affiliated stockholder高管2026年7月30日Entrada Therapeutics, Inc.

US$217万0来源 ↗

331,156 股@ US$6.55Common StockSEC144:0001674324-26-000008

●

5AM Ventures V, L.P.

Affiliated stockholder高管2026年7月30日Entrada Therapeutics, Inc.

US$217万24来源 ↗

331,156 股@ US$6.550.96% mcap44.3% 占其流量Common StockSEC144:0001674324-26-000006

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

5V

5AM Ventures V, L.P.

·SEC (Form 4)

Entrada Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the full record of transactions filed by 5AM Ventures V, L.P.. Insider active across 1 company, notably Entrada Therapeutics, Inc.. In total, 2 disclosures have been logged. History available since 30 July 2026. The latest transaction was disclosed on 30 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is free.